
BioPorto A/S (BIOPOR.CO) Return on Invested Capital (ROIC)
Market Cap: $610.11M
Avg Volume: 374.04K
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Return on Invested Capital (ROIC) Summary
BioPorto A/S's ROIC measures how effectively the company uses its invested capital to generate profits:
- Annual: -82.14%
- Quarterly: -22.17%
- TTM: -69.24%
What is ROIC?
Return on Invested Capital (ROIC) measures how effectively a company uses its capital from debt and equity to generate profits. ROIC is a useful metric for comparing the efficiency of capital allocation between different companies or across time periods within the same company. A higher ROIC indicates a more efficient use of capital.
Related Metrics
Other important metrics to assess BioPorto A/S's profitability include:
- ROE (Return on Equity) - measures the return generated on shareholders' equity:
- Annual: -93.63%
- Quarterly: -24.13%
- TTM: -83.62%
- ROA (Return on Assets) - measures the return generated on the company's assets:
- Annual: -62.72%
- Quarterly: -19.18%
- TTM: -56.29%
These metrics provide insights into BioPorto A/S's profitability and efficiency in using its capital and assets to generate returns. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual ROIC
-82.14%
Quarterly ROIC
-22.17%
TTM ROIC
-69.24%
BioPorto A/S Historical ROIC
Historical ROE
Historical ROA
BioPorto A/S Historical Profitability Metrics
The table below shows various profitability metrics for each year, with the latest data available for the last fiscal year 2023.
Year | ROIC | ROE | ROA |
---|---|---|---|
2023 | -82.14% | -93.63% | -62.72% |
2022 | -89.66% | -108.12% | -69.88% |
2021 | -98.45% | -124.26% | -70.29% |
2020 | -52.28% | -61.01% | -43.88% |
2019 | -232.39% | -275.03% | -163.16% |
2018 | -66.87% | -67.70% | -57.47% |
2017 | -55.57% | -57.51% | -49.15% |
2016 | -50.15% | -51.48% | -45.02% |
2015 | -23.61% | -24.12% | -21.91% |
2014 | -45.37% | -45.06% | -34.71% |
Related Metrics
Explore detailed financial metrics and analysis for BIOPOR.CO.